Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2015 | 1 |
2016 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
robert m
(1,641 results)?
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15.
N Engl J Med. 2023.
PMID: 36920778
Clinical Trial.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators.
Simpson EL, et al.
N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30.
N Engl J Med. 2016.
PMID: 27690741
Free article.
Clinical Trial.
Item in Clipboard
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators.
Griffiths CE, et al.
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
Lancet. 2015.
PMID: 26072109
Clinical Trial.
Item in Clipboard
Syphilis: The great imitator.
Ashton R, Robern M.
Ashton R, et al. Among authors: robern m.
Can Fam Physician. 2023 Oct;69(10):697-698. doi: 10.46747/cfp.6910697.
Can Fam Physician. 2023.
PMID: 37833082
Free PMC article.
No abstract available.
Item in Clipboard
Biologic therapy in psoriasis: perspectives on associated risks and patient management.
Papp KA, Dekoven J, Parsons L, Pirzada S, Robern M, Robertson L, Tan JK.
Papp KA, et al. Among authors: robern m.
J Cutan Med Surg. 2012 May-Jun;16(3):153-68. doi: 10.1177/120347541201600305.
J Cutan Med Surg. 2012.
PMID: 22713438
Review.
Item in Clipboard
Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study.
Werth VP, Fleischmann R, Robern M, Touma Z, Tiamiyu I, Gurtovaya O, Pechonkina A, Mozaffarian A, Downie B, Matzkies F, Wallace D.
Werth VP, et al. Among authors: robern m.
Rheumatology (Oxford). 2022 May 30;61(6):2413-2423. doi: 10.1093/rheumatology/keab685.
Rheumatology (Oxford). 2022.
PMID: 34498056
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite